Axsome Therapeutics is building a portfolio of differentiated product candidates that address unmet medical needs. Some of our product candidates combine multiple mechanisms of action to produce novel medicines that address deficiencies of current approaches. Our pipeline includes four differentiated clinical-stage CNS assets targeting significant and growing markets.

Expanded Access Policy